Als Ltd has released a press release.
ALS H1FY17 Result within Guidance
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from ALS
- Half Year Report (App 4D) ended 30 Sept 2016
- Chairman Elects AGM address (inc. First Half FY17 guidance)
- Rejection of Non-Binding Indicative Proposal
- Preliminary Final Report (App 4E) - year ended 31.3.16
- ALS sells Chemical Division & acquires European Enviro Labs
Later from ALS
- ALS acquires TECAM Laboratory Group in Brazil
- Raj Naran to succeed Greg Kilmister as ALS CEO and MD
- ALS acquires Leochimica Laboratory in Italy
- Preliminary Final Report (App 4E) year ended 31.3.17
- ALS finalises two strategic acquisitions
Follow ALS into a list and get an email when it puts out news.
Follow ALS